1. Home
  2. CHA vs ALKS Comparison

CHA vs ALKS Comparison

Compare CHA & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHA
  • ALKS
  • Stock Information
  • Founded
  • CHA 2017
  • ALKS 1987
  • Country
  • CHA China
  • ALKS Ireland
  • Employees
  • CHA N/A
  • ALKS N/A
  • Industry
  • CHA
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHA
  • ALKS Health Care
  • Exchange
  • CHA NYSE
  • ALKS Nasdaq
  • Market Cap
  • CHA 5.5B
  • ALKS 4.8B
  • IPO Year
  • CHA 2025
  • ALKS 1991
  • Fundamental
  • Price
  • CHA $28.01
  • ALKS $30.84
  • Analyst Decision
  • CHA
  • ALKS Buy
  • Analyst Count
  • CHA 0
  • ALKS 13
  • Target Price
  • CHA N/A
  • ALKS $38.85
  • AVG Volume (30 Days)
  • CHA 1.1M
  • ALKS 1.6M
  • Earning Date
  • CHA 05-30-2025
  • ALKS 07-23-2025
  • Dividend Yield
  • CHA N/A
  • ALKS N/A
  • EPS Growth
  • CHA 186.29
  • ALKS N/A
  • EPS
  • CHA 1.95
  • ALKS 2.09
  • Revenue
  • CHA $1,699,604,333.00
  • ALKS $1,513,770,000.00
  • Revenue This Year
  • CHA N/A
  • ALKS N/A
  • Revenue Next Year
  • CHA N/A
  • ALKS $4.11
  • P/E Ratio
  • CHA $14.34
  • ALKS $14.52
  • Revenue Growth
  • CHA 167.35
  • ALKS N/A
  • 52 Week Low
  • CHA $27.21
  • ALKS $22.90
  • 52 Week High
  • CHA $41.80
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • CHA N/A
  • ALKS 47.14
  • Support Level
  • CHA N/A
  • ALKS $29.20
  • Resistance Level
  • CHA N/A
  • ALKS $30.57
  • Average True Range (ATR)
  • CHA 0.00
  • ALKS 0.70
  • MACD
  • CHA 0.00
  • ALKS -0.10
  • Stochastic Oscillator
  • CHA 0.00
  • ALKS 27.54

About CHA CHAGEE HOLDINGS LTD SPON ADS EACH R SPON ADS EACH REP 1 CL A

Chagee Holdings Ltd is a premium tea drinks brand. It is engaged in the sales of freshly-made tea drinks, related raw materials, packaging, teahouse equipment and other supplies in China.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: